Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1994-11-22
pubmed:abstractText
Single-modality radiotherapy is still considered standard treatment for patients with locally advanced unresectable cancer of the head and neck. As treatment outcome is poor, attempts to integrate chemotherapy into the overall management of these patients are ongoing.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
513-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7918123-Adult, pubmed-meshheading:7918123-Aged, pubmed-meshheading:7918123-Alopecia, pubmed-meshheading:7918123-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7918123-Carcinoma, Squamous Cell, pubmed-meshheading:7918123-Chi-Square Distribution, pubmed-meshheading:7918123-Cisplatin, pubmed-meshheading:7918123-Disease-Free Survival, pubmed-meshheading:7918123-Drug Administration Schedule, pubmed-meshheading:7918123-Female, pubmed-meshheading:7918123-Fluorouracil, pubmed-meshheading:7918123-Head and Neck Neoplasms, pubmed-meshheading:7918123-Humans, pubmed-meshheading:7918123-Leukopenia, pubmed-meshheading:7918123-Male, pubmed-meshheading:7918123-Middle Aged, pubmed-meshheading:7918123-Neoplasm Metastasis, pubmed-meshheading:7918123-Neoplasm Recurrence, Local, pubmed-meshheading:7918123-Patient Compliance, pubmed-meshheading:7918123-Phlebitis, pubmed-meshheading:7918123-Remission Induction
pubmed:year
1994
pubmed:articleTitle
A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.
pubmed:affiliation
Regina Elena National Cancer Institute, Rome, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II